Isofol MedicalIt’s all about the data
Colorectal cancer (CRC) is one of the largest cancer markets where chemotherapy is a backbone therapy. Today, c365,000 patients on chemotherapy treatment also receive folate-based drugs to enhance the cytotoxic effect. Isofol Medical aims that its key drug candidate, arfolitixorin, will become the preferred folate-based therapy as a standard of care therapy in CRC treatment.
DNB Markets is the investment banking arm of DNB Bank ASA and is focused primarily on the Nordic region, as well as internationally on niches such as global shipping, energy and related services, and seafood. DNB Markets offers services in FICC, Equities and Investment Banking advisory from offices in Oslo, Stockholm, London, Singapore and New York. Equity research coverage is offered on c250 Nordic companies. DNB was ranked no.2 in Extel Nordic Research 2017. The DNB Markets’ Credit and FICC Macro & FX Research teams are repeatedly highly rated by Prospera Nordic Institutional Investor Surveys.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.